Sana Biotechnology Overview
- Founded
- 2018
- Status
- Public
- Employees
- 354
- Stock Symbol
- SANA
- Investments
- 4
- Share Price
- $5.24
- (As of Monday Closing)
Sana Biotechnology General Information
Description
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
- 188 East Blaine Street
- Suite 400
- Seattle, WA 98102
- United States
Sana Biotechnology Timeline
Sana Biotechnology Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.24 | $5.40 | $5.19 - $33.80 | $1.02B | 189M | 976K | -$2.40 |
Sana Biotechnology Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|
| EV | 3,450,617 | ||
| Revenue | 0 | 0 | 0 |
| EBITDA | (349,411) | (280,131) | (139,355) |
| Net Income | (358,367) | (285,305) | (130,778) |
| Total Assets | 1,232,751 | 730,296 | 415,192 |
| Total Debt | 98,905 | 71,909 | 47,701 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sana Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Sana Biotechnology‘s full profile, request access.
Request a free trialSana Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore Sana Biotechnology‘s full profile, request access.
Request a free trialSana Biotechnology Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to t
Drug Discovery
Seattle, WA
354
As of 2021
00.000
0.00
0000-00-00
00000000
00.000
0000000
tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
0000000000000
Berkeley, CA
00
As of 0000
00000
0000
0000-00-00
00000000
00000
00000000
ore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000000000000
Cambridge, MA
00
As of 0000
00000
0000
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSana Biotechnology Competitors (4)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Caribou Biosciences | Formerly VC-backed | Berkeley, CA | 00 | 00000 | 00000000 | 00000 |
| 00000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
| 000000 00000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 |
Sana Biotechnology Patents
Sana Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-645872-A | Method for the production of a catalyst | Expired | 31-May-1943 | 0000000000 |
Sana Biotechnology Executive Team (14)
Sana Biotechnology Board Members (18)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alise Reicin MD | Self | Board Member | 000 0000 |
| Donald Payan MD | Sana Biotechnology | Board Member | 000 0000 |
| Douglas Cole MD | Flagship Pioneering | Board Member | 000 0000 |
| Geoffrey von Maltzahn Ph.D | Self | Board Member | 000 0000 |
| Hans Bishop | Sana Biotechnology | Co-Founder & Chairman | 000 0000 |
Sana Biotechnology Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSana Biotechnology Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Sana Biotechnology‘s full profile, request access.
Request a free trialSana Biotechnology Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 | 30-Oct-2020 | 0000000000 | Discovery Tools (Healthcare) | ||
| 0000000000 | 12-Nov-2019 | 0000000000 | 000 | Biotechnology | |
| 000000 000000 | 11-Jun-2019 | 00000 0000 | Discovery Tools (Healthcare) | ||
| Cobalt Biomedicine | 01-Feb-2019 | Merger/Acquisition | 00000 | Drug Delivery | 00000 000 |